Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

GSK Settles Paxil Lawsuit

July 20, 2010 6:26 am | by Wayne Ortman | News | Comments

A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files.


Second J & J Plant Under Federal Investigation

July 20, 2010 6:16 am | News | Comments

A second Johnson & Johnson medicine factory is under scrutiny from federal regulators, while the company struggles to deal with bad publicity and repeated recalls at another factory.


Pfizer Halts Another Tanezumab Trial

July 20, 2010 6:12 am | by Linda A. Johnson | News | Comments

Drugmaker Pfizer Inc. has stopped patient tests of an experimental drug for two types of pain at the request of federal regulators, just weeks after halting its testing in arthritis patients.


DiTEBA And Thesis Announce Service Collaboration

July 19, 2010 10:12 am | News | Comments

DiTEBA Research Laboratories Inc. and Thesis Chemistry Inc. announced a collaboration that will bring together their proven technical expertise in process chemistry, cGMP chemical production and analytical testing.


CIT Now Offering DBS Testing

July 19, 2010 8:52 am | News | Comments

CIT, an independent preclinical contract research organization (CRO), is now offering the Dried Blood Spot (DBS) technique to its clients worldwide. The new service is in line with CIT’s policy of continuous enhancements to the range it offers its customers.


AAIPharma Partners With CritiTech Over Nanotech

July 19, 2010 8:46 am | News | Comments

AAIPharma Services Corp., a biopharmaceutical drug product development and contract manufacturing company, and CritiTech, Inc., a nanotechnology company that improves the delivery of therapeutic molecules, have announced a strategic alliance to expand the reach of the CritiTech technology.


Droplet Starter System

July 19, 2010 8:27 am | Drug Discovery & Development | Product Releases | Comments

Dolomite has introduced the modular Syringe-based Droplet Starter System, which enables users to produce more than 10,000 monodispersed droplets per second, ranging from Ø20 to 250µm.


Refractive Index Detection

July 19, 2010 8:16 am | Product Releases | Comments

Wyatt Technology Corporation, a leader in absolute macromolecular characterization instrumentation and software, announces the launch of its brand new Refractive Index (RI) detection instrument - the Optilab T-rEX.


Novasep And instrAction Ally Over Chromatography

July 19, 2010 8:01 am | News | Comments

Novasep, a leading supplier of manufacturing solutions to the life science industries, and instrAction, a manufacturer of innovative chromatographic stationary phases for API purification processes, announced that they have entered into a strategic alliance.


Biofocus Collaborating With Bristol On Neuropathic Pain

July 19, 2010 7:52 am | News | Comments

BioFocus and the University of Bristol announced a new drug discovery collaboration aimed at developing treatments for chronic pain associated with diabetes (diabetic neuropathic pain).


Musashi Implicated In Blast-Crisis CML

July 19, 2010 7:42 am | News | Comments

Researchers at Duke University Medical Center have identified a mechanism that could explain how patients move into the worst phase of chronic myelogenous leukemia (CML).


Protein Helps Stem Cells Stay Pluripotent

July 19, 2010 7:27 am | News | Comments

Take a skin cell from a patient with Type 1 diabetes. Strip out everything that made it a skin cell, then reprogram it to grow into a colony of pancreatic beta cells.


FDA Grants Priority Review to Denosumab

July 19, 2010 7:10 am | News | Comments

Amgen announced that the U.S. Food and Drug Administration (FDA) has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events (SREs) in patients with cancer.


Abbott Presents PROGRESS Results

July 19, 2010 7:05 am | News | Comments

Abbott presented 48-week findings comparing an HIV regimen of its protease inhibitor, Kaletra, and Merck's integrase inhibitor, Isentress, to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors in Truvada in antiretroviral-naive adult patients.


New Flu Vaccine May Come Via Patch

July 19, 2010 6:29 am | by Randolph E. Schmid | News | Comments

One day your annual flu shot could come in the mail. At least that's the hope of researchers developing a new method of vaccine delivery that people could even use at home: a patch with microneedles.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.